Showing results (51-60 of 584) with videos related to

Sort By:
Pageof 59
Annals of Diagnostic Pathology|May 23, 2020
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 casesVincent Thomas de Montpréville, Ludovic Lacroix, Etienne Rouleau, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2026
Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancerDanny Lavigne, Cecile Le Péchoux, Angela Botticella, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Small cell lung cancer: new clinical recommendations and current status of biomarker assessmentDavid Planchard, Cécile Le Péchoux
Oncology (Williston Park, N.Y.)|June 24, 2009
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancerBenjamin Besse, Thierry Le Chevalier
Bulletin Du Cancer|November 27, 2002
[Gemcitabine and breast cancer]Benjamin Besse, Jean-Philippe Spano
Translational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin Besse
Pageof 59